% | $
Quotes you view appear here for quick access.

Krispy Kreme Doughnuts, Inc. Message Board

cash2go 153 posts  |  Last Activity: 7 hours ago Member since: Feb 8, 2006
  • Reply to

    Sold half my position

    by cash2go Feb 18, 2015 1:38 AM
    cash2go cash2go Mar 4, 2015 4:56 PM Flag

    Sucks, just saw where I sold the rest of my position on today's spike. Who knows where this short squeeze will take this one, GLTA.

  • Reply to

    BMY Cancer Drug Approval

    by jbdever58 Mar 4, 2015 2:52 PM
    cash2go cash2go Mar 4, 2015 3:49 PM Flag

    May 14, 2014

    Bristol-Myers Squibb and Celldex Therapeutics Announce Clinical Trial Collaboration to Evaluate the Combination of Investigational Immunotherapies Nivolumab and Varlilumab

    *Before selling on this pop everyone should take 30 minutes to review the promise of PD-1 and how it works with immune based cancer therapy.

  • Reply to

    What Causes Trigger Finger?

    by cash2go Mar 2, 2015 10:24 AM
    cash2go cash2go Mar 4, 2015 3:23 PM Flag

    Price goes higher and algo shorts pile on. You Wall Street guys need to pull the plug and fire the boys that wrote that algo you are using.

  • Reply to

    U.S. Strategic National Stockpile for Smallpox

    by cash2go Feb 26, 2015 5:20 PM
    cash2go cash2go Mar 4, 2015 12:46 PM Flag

    Perelman could give a shite about animosities. He wants to pocket every last dollar possible. He is a billionaire.
    Just a few of the pluses that come with a settlement:

    Settle the case and Siga can use it's $54M already written down in BK court, I'm sure there is a lot more. Settle with a merger and Pharmathene has at least $100M plus of tax loss carry forwards.

    It's business. Lets just all hope we have decent management teams when it comes time to rewarding shareholders

  • Reply to

    U.S. Strategic National Stockpile for Smallpox

    by cash2go Feb 26, 2015 5:20 PM
    cash2go cash2go Mar 4, 2015 12:00 AM Flag

    Cash is not going to be a problem. Siga wants to use it's best accounting tricks to maximize writeoffs...and then I suspect to hear of a negotiated settlement. Settle out of court and you don't have bad faith with ill intent on your record and you also could get to keep the lottery ticket of having the only smallpox antiviral shown safe in human trials and 100% effective in primate trials when primates were injected with a lethal dose of smallpox.
    If one case of smallpox turns up you have a multibillion dollar payday. Remember the found CDC smallpox samples found earlier this year. Russia is much less stable and also has viable smallpox stored. You also likely have at least one more BARDA order in the next 5 years.
    Anyone else think Siga has turned the Pharmathene case over to their accounting department at this point? Their legal hand has already done an incredible job to get the settlement as low as it has, $190M.

  • Reply to

    U.S. Strategic National Stockpile for Smallpox

    by cash2go Feb 26, 2015 5:20 PM
    cash2go cash2go Mar 2, 2015 2:31 PM Flag

    Seeing Siga's price action recently maybe they are about to ink another sizable deal. Ebola and Measles stories help American public appreciate value of these programs. NIH says one case of smallpox found in the world would be considered catastrophic.

    Maybe boys getting into Siga know something? That is how Wall Street works. PIP to be gobbled up soon?

  • Reply to

    Teebrane do you use the ignore feature?

    by cash2go Mar 2, 2015 1:36 PM
    cash2go cash2go Mar 2, 2015 2:14 PM Flag

    Have you seen video of opening argument by Siga to Delaware Supreme Court? Ran across actual video with audio of Siga's opening presentation. Google under cvn video and you will find it. At about 2 minutes 30 seconds the attorney states that it is "fact" that Siga and Pharmathene both think the value of -246 has tripled by November 2006.
    (Siga attorney uses the tripling of value as reason that LATS terms should no longer apply)

    I'd be interested in you listening to it and give me your opinion. Another appeal at this point sounds absurd from Siga's viewpoint. I'm fine if you point out negatives in your argument. I don't love or hate a stock, I do enjoy a sensible conservation.

  • The shorts are so focused on discrediting Teebrane, it's replaced the wild speculation articles. I've seen little valuable input from the negative posters on this board.

    The original "non binding" negative posters are the real gut busters.

    Hang in there and know that your posting some very valuable insights that are read by many that are here for the long run.

  • Reply to

    Trouble in Pipville

    by sellhighdrinklow Mar 2, 2015 12:35 PM
    cash2go cash2go Mar 2, 2015 1:21 PM Flag

    I'm in no rush and have cleared cash to collect on price panics from here. This bottoming out and creep up has my trigger finger itching, especially with the Siga boyz getting some strong action.

    Pharmathene is up another $34 grand today.

  • Being short Portola.

  • No Needle. Gonna be a huge hit.

    Short term Big Pharma will battle Afreeza with everything the got. Buy the dips and hang on for a few years.

  • Reply to

    Sanofi rep in my office today.

    by doctor.stockpicker Feb 26, 2015 6:10 PM
    cash2go cash2go Mar 2, 2015 2:06 AM Flag

    Interesting observation on less basal needed.
    A1C's are going to improve with compliance and fewer post prandial spikes not occurring means less basal insulin needed to maintain targeted A1C.
    I'm guessing the compliance issue with mealtime injections is much larger than calculated. Affrezza gonna be so much simpler and why would anyone skip it because you don't have the annoying needle #$%$...

  • Reply to

    American Bar Association

    by cash2go Feb 27, 2015 12:13 AM
    cash2go cash2go Mar 1, 2015 2:55 AM Flag

    (Siga not required to pay expert witness that was not helpful)
    * Siga will be required to help pay for witness testimony that was considered helpful in determining reasonable expectations.

    Some (((speculation))) has to be used to determine reasonable expectations. Are we still beating that dead horse?

17.39+0.12(+0.69%)May 28 4:04 PMEDT